Trump administration details state of healthcare competition

In the midst of a major consolidation period in the healthcare industry, a new report from the Trump administration sheds light on the current state of competition in the space.

The report takes a hard look at regulations and laws that govern the healthcare industry and attempts to weight their impact on competition, as well as the impact on making care more affordable and higher quality. It also specifically notes that the Affordable Care Act “moved the [healthcare] system in the wrong direction" and suggests several proposals to improve the healthcare space. 

The report aligns with the Trump administration’s continued effort to deregulate the healthcare industry and undo many provisions of the healthcare law by claiming the ACA’s rules and regulations are harmful.

“Healthcare markets could work more efficiently and Americans could receive more effective, high-value care if we remove and revise certain federal and state regulations and policies that inhibit choice and competition,” the report reads.

Choice and competition

Lower competition leads to higher prices for consumers, while some government policies strain the healthcare workforce, according to the report. Market competition should lead providers to charge more competitive rates for healthcare services while also providing higher-quality care. More competition should also theoretically boost choices for consumers, but these incentives disappear when competitive pressures are missing.

Consolidation has rapidly intensified across the healthcare sector over the last several years, leading lawmakers to question the impact on Medicare prices. In markets with fewer insurers, prices for healthcare insurance premiums tend to be higher, according to research. The same is true of hospital prices in markets with less competition.

The report takes aim at rules and regulations that may “impede market forces,” including third-party payments that hide prices, metrics and shopping realities.

“The common claim that the healthcare sector as a whole cannot function under free-market principles is not true,” the report reads.

Market corrections

To improve the state of the healthcare industry as the government continues to spend more on services and care, the report outlined several ways to boost competition.

The report specifically addressed the healthcare workforce, recommending incentives like increasing reimbursement for telehealth and increasing the scope of what some practitioners can do. Regulatory changes would also provide more flexibility for licenses and enable telehealth across state lines.

Within the insurance markets, the report recommends scaling back ACA rules, including employer mandates. The administration also promotes expanding short-term, limited-duration health plans, which are not comprehensive and do not have to follow Obamacare requirements such as providing coverage for pre-existing conditions. The Trump administration recently expanded the use of these plans earlier this year––a decision that has been met with controversy.

The report further recommended changes in provider markets to repeal restrictions, namely around physician-owned hospitals, and allow the Federal Trade Commission (FTC) to monitor nonprofit providers.

The report was met with mixed reactions from industry associations.

“Based on our initial read, we are pleased by several of the proposals put forth in today’s report, such as those to broaden providers’ scope of practice and expand access to telehealth, which will improve access to care for patients,” Executive Vice President of the American Hospital Association Tom Nickels said in a statement. “At the same time, we strongly oppose attempts to loosen the current restrictions on physician-owned hospitals." 

AHA also opposed the proposal to restructure graduate medical education funding that “would result in less federal support for physician training.”

Similarly, the Federation of American Hospitals opposed lifting restrictions on physician-owned hospitals, among other proposals.

“Too many elements of the Administration’s report resort to the same old bromides that got us here in the first place, and would reverse the progress hospitals and others are hard at work on,” FAH CEO and President Chip Kahn said in a statement. “Further, the report ignores that a key to patient access is to ensure community hospitals have the resources they need to provide lifesaving care for anyone who walks through our doors 24/7.”

HHS prepared the report along with the Departments of the Treasury and Labor, the FTC and other White House offices.

Find the full report here.

Amy Baxter

Amy joined TriMed Media as a Senior Writer for HealthExec after covering home care for three years. When not writing about all things healthcare, she fulfills her lifelong dream of becoming a pirate by sailing in regattas and enjoying rum. Fun fact: she sailed 333 miles across Lake Michigan in the Chicago Yacht Club "Race to Mackinac."

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.